Product Description

Baritroz 2.5mg Tablet consists of the active ingredient Letrozole. It is indicated as first-line therapy for women with early and advanced breast cancer whose tumors are hormone receptor-positive. This medicine can be used before surgery to shrink the tumor or after surgery to prevent cancer recurrence.

 

Inform your physician if you have not attained menopause yet, as this medicine does not work for premenopausal women. This medicine could also disrupt bone mineral density and increases cholesterol levels. Hence, your physician must monitor your bone functions and cholesterol levels at regular intervals.

 

Uses of Baritroz  2.5mg Tablet:

• Adjunct to standard treatment for postmenopausal women with early breast cancer.
• Treatment of hormone receptor-positive or unknown advanced breast cancer in postmenopausal women.

How to use

Use as directed

Uses

Treatment of Breast cancer

Side Effects

• Hot flashes
• Arthralgia
• Swelling
• Headache
• Dizziness
• Increased cholesterol levels
• Sweating
• Bone and musculoskeletal pain
• Vaginal dryness
• Nausea, vomiting, indigestion, diarrhea

Storage

Store below 30℃